Level C· Early human research exploring benefitsCase Report / SeriesPubMed

Hirsutism Induced by Facial Autologous Fat Grafting.

Ramot Y., Silyuk T., Murad S., Zlotogorski A.

Case Report / Series on Face & Skin, Hair & Scalp, published in Skin Appendage Disord (2019) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Case Report / Series
Journal
Skin Appendage Disord (2019)
Country
Switzerland
Reported sample size
—
Source database
PubMed
PMID
32021861
PMCID
PMC6995947
DOI
10.1159/000502444
Citations
8

Abstract (original English)

Autologous fat grafting (AFG) is a common procedure, which gains popularity for a large number of indications, mainly for reshaping and filling of contour defects. It is considered a safe procedure, with only uncommon and mild complications. Here we report on a 60-year-old female patient who developed excess hair growth on both cheeks 1 month following facial AFG done in conjunction with a facelift. Complete endocrine evaluation was within normal levels. Previous reports have suggested that adipocyte mesenchymal stem cells can secrete a number of growth factors, which in turn can lead to activation of stem cells in the hair follicle, affecting their growth. However, to the best of our knowledge, this is the first report on hirsutism as a side effect of AFG.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • Without an adequate control group, treatment effects cannot be separated from other factors.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research